A detailed history of Rfp Financial Group LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Rfp Financial Group LLC holds 65 shares of MRNA stock, worth $4,738. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65
Previous 62 4.84%
Holding current value
$4,738
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$101.21 - $166.61 $303 - $499
3 Added 4.84%
65 $7,000
Q1 2024

May 09, 2024

SELL
$85.37 - $115.44 $3,329 - $4,502
-39 Reduced 38.61%
62 $6,000
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $2,988 - $4,490
43 Added 74.14%
101 $10,000
Q1 2023

Apr 26, 2023

SELL
$135.66 - $197.02 $6,783 - $9,851
-50 Reduced 46.3%
58 $8.91 Million
Q4 2022

Jan 24, 2023

BUY
$118.38 - $210.04 $12,785 - $22,684
108 New
108 $19.4 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $28.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Rfp Financial Group LLC Portfolio

Follow Rfp Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfp Financial Group LLC with notifications on news.